[Shenzhen, China, Sept. 15th, 2023] – SeekIn Inc., a leading company pioneering in blood-based cancer early detection, proudly announces the participation of Dr. Mao, CEO and Co-founder, in the highly anticipated BIOHK2023 conference. The CEO took the stage to...
Your body is as unique as your fingerprint. The way we maintain your health and treat diseases should also be unique and 100% compatible with your original genetic and epigenetic codes. At Ovital Institute we initiated personalised nutrition pilot studies on cancer...
A step closer to multi-cancer early diagnosis availability for patients in low- and middle-income countries Please note that the full article was originally published in Health Management Journal Volume 23 – Issue 3 The scale of destruction wreaked on human life...
The patient perspective on pharmaceutical expanded access programmes (EAPs) Introduction Pharmaceutical expanded access programmes (EAPs), also referred to as “compassionate use” programmes, are designed to provide later-stage patients with access to new...
We are on a mission to inspire and empower patients, researchers and clinicians to work together to prevent, treat and eliminate cancer. We are honoured that Professor Friend is one of our ambassadors. He has been a good relation and advisor for Inspire2Live since the...
